These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 11337355)
1. FE65 in Alzheimer's disease: neuronal distribution and association with neurofibrillary tangles. Delatour B; Mercken L; El Hachimi KH; Colle MA; Pradier L; Duyckaerts C Am J Pathol; 2001 May; 158(5):1585-91. PubMed ID: 11337355 [TBL] [Abstract][Full Text] [Related]
2. Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease. Iyaswamy A; Thakur A; Guan XJ; Krishnamoorthi S; Fung TY; Lu K; Gaurav I; Yang Z; Su CF; Lau KF; Zhang K; Ng RC; Lian Q; Cheung KH; Ye K; Chen HJ; Li M Signal Transduct Target Ther; 2023 Oct; 8(1):404. PubMed ID: 37867176 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517 [TBL] [Abstract][Full Text] [Related]
4. Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles. Colle MA; Duyckaerts C; Laquerrière A; Pradier L; Czech C; Checler F; Hauw JJ Neuropathol Appl Neurobiol; 2000 Apr; 26(2):117-23. PubMed ID: 10840274 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease. Ferrer I Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Perry G; Richey PL; Siedlak SL; Smith MA; Mulvihill P; DeWitt DA; Barnett J; Greenberg BD; Kalaria RN Am J Pathol; 1993 Dec; 143(6):1586-93. PubMed ID: 7504885 [TBL] [Abstract][Full Text] [Related]
8. Expression of the Fe65 adapter protein in adult and developing mouse brain. Kesavapany S; Banner SJ; Lau KF; Shaw CE; Miller CC; Cooper JD; McLoughlin DM Neuroscience; 2002; 115(3):951-60. PubMed ID: 12435432 [TBL] [Abstract][Full Text] [Related]
9. Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi. Shijo M; Honda H; Suzuki SO; Hamasaki H; Hokama M; Abolhassani N; Nakabeppu Y; Ninomiya T; Kitazono T; Iwaki T Brain Pathol; 2018 Jan; 28(1):58-71. PubMed ID: 27997051 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of FE65 Ser610 by serum- and glucocorticoid-induced kinase 1 modulates Alzheimer's disease amyloid precursor protein processing. Chow WN; Ngo JC; Li W; Chen YW; Tam KM; Chan HY; Miller CC; Lau KF Biochem J; 2015 Sep; 470(3):303-17. PubMed ID: 26188042 [TBL] [Abstract][Full Text] [Related]
12. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
13. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Maccioni RB; Muñoz JP; Barbeito L Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751 [TBL] [Abstract][Full Text] [Related]
14. FE65 regulates and interacts with the Bloom syndrome protein in dynamic nuclear spheres - potential relevance to Alzheimer's disease. Schrötter A; Mastalski T; Nensa FM; Neumann M; Loosse C; Pfeiffer K; Magraoui FE; Platta HW; Erdmann R; Theiss C; Uszkoreit J; Eisenacher M; Meyer HE; Marcus K; Müller T J Cell Sci; 2013 Jun; 126(Pt 11):2480-92. PubMed ID: 23572515 [TBL] [Abstract][Full Text] [Related]
15. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. Fiore F; Zambrano N; Minopoli G; Donini V; Duilio A; Russo T J Biol Chem; 1995 Dec; 270(52):30853-6. PubMed ID: 8537337 [TBL] [Abstract][Full Text] [Related]
16. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655 [TBL] [Abstract][Full Text] [Related]
18. Effects of the Pentapeptide P33 on Memory and Synaptic Plasticity in APP/PS1 Transgenic Mice: A Novel Mechanism Presenting the Protein Fe65 as a Target. Szögi T; Schuster I; Borbély E; Gyebrovszki A; Bozsó Z; Gera J; Rajkó R; Sántha M; Penke B; Fülöp L Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234498 [TBL] [Abstract][Full Text] [Related]
19. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease. Gómez-Ramos P; Morán MA Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459 [TBL] [Abstract][Full Text] [Related]
20. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease. Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]